Andrew Oster: The power of collaborative care in transitioning to biosimilars

Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises the importance of consistent communication to ensure pharmacists, patients and prescribers are informed of what is being dispensed at the pharmacy level.   This video

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Looking at the market
Next PSOTY winner revealed